Related references
Note: Only part of the references are listed.Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients
Valentina Marchica et al.
CANCERS (2019)
Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth
Sri HariKrishna Vellanki et al.
CANCER LETTERS (2019)
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients
Patrizia Leone et al.
ONCOIMMUNOLOGY (2019)
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma
A. G. Solimando et al.
LEUKEMIA (2018)
Consensus guidelines for the use and interpretation of angiogenesis assays
Patrycja Nowak-Sliwinska et al.
ANGIOGENESIS (2018)
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis
Mikhail M. Savitski et al.
CELL (2018)
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study
Luigia Rao et al.
Oncotarget (2018)
MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
Jiazhi Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression
Barbara Castella et al.
FRONTIERS IN IMMUNOLOGY (2018)
Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer
Johnny R. Ramroop et al.
FRONTIERS IN ONCOLOGY (2018)
Junctional adhesion molecule-A: functional diversity through molecular promiscuity
Tim Steinbacher et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma
Y. Qin et al.
LEUKEMIA (2017)
Epitope characterization of anti-JAM-A antibodies using orthogonal mass spectrometry and surface plasmon resonance approaches
Guillaume Terral et al.
MABS (2017)
JUNCTIONAL ADHESION MOLECULES (JAMs): CELL ADHESION RECEPTORS WITH PLEIOTROPIC FUNCTIONS IN CELL PHYSIOLOGY AND DEVELOPMENT
Klaus Ebnet
PHYSIOLOGICAL REVIEWS (2017)
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein
Imen Jridi et al.
TOXICON (2017)
A novel immunotoxin reveals a new role for CD321 in endothelial cells
Takeshi Fukuhara et al.
PLOS ONE (2017)
CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myeloma
Johannes M. Waldschmidt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Alisertib Induces Cell Cycle Arrest, Apoptosis, Autophagy and Suppresses EMT in HT29 and Caco-2 Cells
Bao-Jun Ren et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response
Paola Cappello et al.
ONCOIMMUNOLOGY (2016)
Immunoregulatory roles of versican proteolysis in the myeloma microenvironment
Chelsea Hope et al.
BLOOD (2016)
Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling
Xing-Ding Zhang et al.
CANCER CELL (2016)
Targeting vasculogenesis to prevent progression in multiple myeloma
M. Moschetta et al.
LEUKEMIA (2016)
Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma
Yuan-Quan Yu et al.
ONCOTARGET (2016)
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
Jacqueline E. Noll et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
Roberto Ria et al.
CLINICAL CANCER RESEARCH (2014)
A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target
Arianna Ferrucci et al.
CLINICAL CANCER RESEARCH (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Down-Regulation of CD9 by Methylation Decreased Bortezomib Sensitivity in Multiple Myeloma
Xiaotong Hu et al.
PLOS ONE (2014)
Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
Michele Moschetta et al.
CLINICAL CANCER RESEARCH (2013)
Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling
Swetha S. D. Peddibhotla et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Relocalization of Junctional Adhesion Molecule A during Inflammatory Stimulation of Brain Endothelial Cells
Svetlana M. Stamatovic et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
S. Vincent Rajkumar et al.
BLOOD (2011)
Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells
Shih-Hsin Tu et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
ADAMTS1 Contributes to the Acquisition of an Endothelial-like Phenotype in Plastic Tumor Cells
Carmen Casal et al.
CANCER RESEARCH (2010)
Mechanisms of Outside-in Signaling at the Tight Junction by Junctional Adhesion Molecule A
Eric A. Severson et al.
MOLECULAR STRUCTURE AND FUNCTION OF THE TIGHT JUNCTION: FROM BASIC MECHANISMS TO CLINICAL MANIFESTATIONS (2009)
Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases
Rory R. Koenen et al.
BLOOD (2009)
Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival
Elke De Bruyne et al.
CLINICAL CANCER RESEARCH (2008)
Mouse models of human myeloma
Constantine S. Mitsiades et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-A-deficient mice
Vesselina G. Cooke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
The gelatin sponge-chorioallantoic membrane assay
Domenico Ribatti et al.
NATURE PROTOCOLS (2006)
Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells
P Rossignol et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: Role in inflammatory thrombosis
A Babinska et al.
THROMBOSIS AND HAEMOSTASIS (2002)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin
G Bazzoni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
